重型再生障碍性贫血骨髓移植预处理方案的选择
该研究评估了重型再生障碍性贫血患者接受HLA相合同胞及无关供者骨髓移植时不同预处理方案的疗效。同胞移植中,Flu/Cy/ATG或Cy/ATG方案生存最佳;无关供者移植中各方案生存无差异,但兔源ATG可降低急性GVHD风险。
要点
- HLA相合同胞骨髓移植首选Flu/Cy/ATG或Cy/ATG预处理方案。
- 无关供者移植中兔源ATG较马源ATG降低II-IV度急性GVHD风险。
- 年龄>30岁是同胞及无关供者移植生存降低的独立不良因素。
核心结论
- Flu/Cy/ATG和Cy/ATG是HLA相合同胞骨髓移植治疗重型再生障碍性贫血的最佳预处理方案。
- 无关供者骨髓移植中各预处理方案生存无差异,但兔源ATG因降低急性GVHD风险可能更受青睐。
研究设计与样本
- 回顾性评估接受HLA相合同胞供者骨髓移植(n=955)和8/8或7/8 HLA等位基因匹配无关供者骨髓移植(n=409)的重型再生障碍性贫血患者。
关键数值与推荐
- 同胞移植:Flu/Cy/ATG或Cy/ATG方案5年生存率91%。
临床怎么用
- HLA相合同胞骨髓移植治疗重型再生障碍性贫血优先选择Flu/Cy/ATG或Cy/ATG预处理。
- 无关供者骨髓移植可考虑使用兔源ATG以降低急性GVHD风险。
- 年龄>30岁患者移植前应充分评估风险并个体化选择方案。
局限性
- 回顾性研究设计可能存在选择偏倚。
- 无关供者移植样本量较小(n=409),可能影响方案间差异的检出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Allogeneic bone marrow transplantation (BMT) is curative therapy for the treatment of patients with severe aplastic anemia (SAA). However, several conditioning regimens can be used for BMT. We evaluated transplant conditioning regimens for BMT in SAA after HLA-matched sibling and unrelated donor BMT. For recipients of HLA-matched sibling donor transplantation (n = 955), fludarabine (Flu)/cyclophosphamide (Cy)/antithymocyte globulin (ATG) or Cy/ATG led to the best survival. The 5-year probabilities of survival with Flu/Cy/ATG, Cy/ATG, Cy ± Flu, and busulfan/Cy were 91%, 91%, 80%, and 84%, respectively (P = .001). For recipients of 8/8 and 7/8 HLA allele-matched unrelated donor transplantation (n = 409), there were no differences in survival between regimens. The 5-year probabilities of survival with Cy/ATG/total body irradiation 200 cGy, Flu/Cy/ATG/total body irradiation 200 cGy, Flu/Cy/ATG, and Cy/ATG were 77%, 80%, 75%, and 72%, respectively (P = .61). Rabbit-derived ATG compared with equine-derived ATG was associated with a lower risk of grade II to IV acute graft-versus-host disease (GVHD) (hazard ratio [HR], 0.39; P < .001) but not chronic GVHD. Independent of conditioning regimen, survival was lower in patients aged >30 years after HLA-matched sibling (HR, 2.74; P < .001) or unrelated donor (HR, 1.98; P = .001) transplantation. These data support Flu/Cy/ATG and Cy/ATG as optimal regimens for HLA-matched sibling BMT. Although survival after an unrelated donor BMT did not differ between regimens, use of rabbit-derived ATG may be preferred because of lower risks of acute GVHD.
引用
- Bejanyan N, Kim S, Hebert KM, et al. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Blood Adv. 2019. PMID: 31648332. doi:10.1182/bloodadvances.2019000722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。